Federal Hemp Cliff November 12, 2026 — PL 119-37 § 781

Last verified: May 2026

What PL 119-37 § 781 Does

Buried in the November 12, 2025 federal funding bill (Public Law 119-37), Section 781 tightens the federal definition of hemp first established by the 2018 Agriculture Improvement Act (the "Farm Bill"). The 2018 Farm Bill defined hemp as Cannabis sativa L. with delta-9 THC concentration at or below 0.3% by dry weight, removing it from federal Schedule I. The 0.3% delta-9 threshold — pegged to a single cannabinoid — created the structural opening that produced the THCA-flower / delta-8 / delta-10 / hemp-delta-9 retail markets across the United States.

PL 119-37 § 781 closes that opening. Per Congressional Research Service Report IN12620, the section:

• Tightens the federal hemp definition beyond the simple delta-9 0.3% threshold.
• Caps "intoxicating cannabinoids" in nationally sold hemp products at 0.4 milligrams per package.
• Constrains conversion / isomerization-derived cannabinoids (delta-8, delta-10, HHC, THC-O, THCp).
• Phases in implementation around November 12, 2026.

The 0.4 mg/Package Cap — Why It Matters

The 0.4 mg/package cap is the operationally consequential threshold. For comparison:

• A typical hemp-derived delta-9 gummy contains 5–10 mg per piece; a 30-piece package would contain 150–300 mg.
• A typical hemp beverage permitted under Tennessee’s Public Chapter 526 contains up to 15 mg per serving / 30 mg per container.
• A typical THCA flower 1-gram pre-roll contains roughly 200 mg of decarboxylation-equivalent delta-9.
• A typical CBD-isomerized delta-8 cart contains 500–1,000 mg per cart.

A 0.4 mg/package cap effectively eliminates virtually every consumer-facing hemp-derived intoxicating product in the U.S. market — not just the products Tennessee already banned under Public Chapter 526, but also the naturally-occurring delta-9 edibles and beverages that Tennessee permits within the new framework.

The TDA December 2025 Statement

The Tennessee Department of Agriculture’s December 2025 official statement: "Until TDA has more information, Tennessee’s hemp program will remain unchanged under existing state law while federal agencies develop guidance to implement the new provision." Translation: TDA is waiting for federal-agency rule-making (USDA / FDA / DEA / CBP) to provide implementation guidance before adjusting state-level enforcement and licensing.

The Compounding Effect with Public Chapter 526

Tennessee already has the most restrictive hemp framework in the South under Public Chapter 526 of 2025. The federal cliff layers on top:

• Public Chapter 526 (effective January 1, 2026, full compliance ~June 30, 2026): Bans THCA, THCp, CBD-isomerized delta-8/-10 in Tennessee. Permits naturally-occurring delta-9 within dosage limits.
• PL 119-37 § 781 (effective ~November 12, 2026): Federal cap at 0.4 mg/package likely eliminates the naturally-occurring delta-9 products that Tennessee permits.

The combined effect: by late 2026, the Tennessee legal hemp-derived intoxicant market may be reduced to virtually nothing — primarily non-intoxicating CBD oil, CBG, CBN, and CBC products plus very-low-potency hemp beverages within the federal 0.4 mg cap.

What Federal Agencies Are Doing

Implementation responsibilities fall across multiple agencies:

• USDA: hemp-cultivation rules under the 7 U.S.C. § 1639o framework.
• FDA: hemp-derived consumer-product rules; food, beverage, and dietary-supplement guidance.
• DEA: scheduling clarification for any cannabinoids no longer meeting hemp definition; Schedule III implementation.
• CBP: import / export and interstate-transport enforcement.

As of May 2026, no agency has issued implementing guidance specific to PL 119-37 § 781. Industry, state regulators, and consumer-advocacy groups are awaiting agency action ahead of the November 12, 2026 cliff.

The December 2025 Schedule III Order

Separately, President Trump issued an executive order in December 2025 directing federal agencies to move cannabis from Schedule I to Schedule III under the Controlled Substances Act. Schedule III is a lower-restriction category permitting prescription medical use under DEA registration. This is a significant federal status change but does not, by itself:

• Legalize cannabis for adult-use under federal law.
• Authorize state medical-cannabis programs to operate without Schedule III prescriber compliance.
• Eliminate the IRS § 280E business-tax disability (which applies to all Schedule I and II businesses).
• Override state-law prohibitions in Tennessee, Idaho, Wyoming, Kansas, South Carolina, etc.

Tennessee’s response was SB 1603 (signed April 23, 2026), which expressly stripped state Health and Mental Health/Substance Abuse Services commissioners of authority to align state cannabis scheduling with federal rescheduling without legislative approval. See TACIR / SB 1603 page.

What This Means for Tennessee Consumers and Businesses

Through November 12, 2026: The Tennessee Public Chapter 526 framework governs. Naturally-occurring delta-9 hemp products within state dosage limits remain legal at 21+ retailers. Legacy TDA licensees may sell pre-Public Chapter 526 inventory through license expiration.

After November 12, 2026: Federal 0.4 mg/package cap likely makes virtually all hemp-derived intoxicating products unlawful at the federal level. State enforcement will follow federal guidance. The hemp-derived intoxicant market in Tennessee will likely contract to non-intoxicating CBD / CBG / CBN / CBC products only.

For consumers seeking cannabis products after late 2026, the only legal options will likely be:

• Cross-border travel to Missouri (recreational), Kentucky (medical), Mississippi (medical), Arkansas (medical), Virginia (medical), Alabama (medical), or Georgia (low-THC oil).
• Travel to the EBCI Qualla Boundary in Cherokee, NC (adult-use 21+, consumption tribal-lands only).
• Federally-compliant non-intoxicating CBD products.

Returning to Tennessee with cannabis purchased legally elsewhere remains a state Class E felony at > ½ oz under T.C.A. § 39-17-417 plus federal interstate-commerce exposure.